US Patent Issued to GENMAB on May 26 for "Binding agents binding to PD-L1 and CD137 and use thereof" (Dutch, German Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,515, issued on May 26, was assigned to GENMAB A/S (Valby, Denmark).

"Binding agents binding to PD-L1 and CD137 and use thereof" was invented by Isil Altintas (Utrecht, Netherlands), David Satijn (Utrecht, Netherlands), Rik Rademaker (Utrecht, Netherlands), Paul Parren (Odijk, Netherlands), Ugur Sahin (Mainz, Germany), Friederike Gieseke (Mainz, Germany), Alexander Muik (Mainz, Germany), Christian Grunwitz (Mainz, Germany), Edward Van Den Brink (Utrecht, Netherlands) and Dennis Verzijl (Utrecht, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel binding agents and their use in medicine. In particular, the...